IRME Stock Overview
IR-Med Inc., a development stage medical device company, focuses on the development of non-invasive devices for various medical indications.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
IR-Med Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.90 |
| 52 Week High | US$1.65 |
| 52 Week Low | US$0.35 |
| Beta | 1.44 |
| 1 Month Change | -30.98% |
| 3 Month Change | -40.00% |
| 1 Year Change | 125.56% |
| 3 Year Change | -77.50% |
| 5 Year Change | -92.42% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| IRME | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -5.3% | -1.3% | -0.7% |
| 1Y | 125.6% | -2.1% | 22.8% |
Return vs Industry: IRME exceeded the US Medical Equipment industry which returned -2% over the past year.
Return vs Market: IRME exceeded the US Market which returned 22.3% over the past year.
Price Volatility
| IRME volatility | |
|---|---|
| IRME Average Weekly Movement | 20.1% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IRME's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IRME's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 8 | Ronnie Klein | www.ir-medical.com |
IR-Med Inc., a development stage medical device company, focuses on the development of non-invasive devices for various medical indications. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. The company is headquartered in Rosh Pinna, Israel.
IR-Med Inc. Fundamentals Summary
| IRME fundamental statistics | |
|---|---|
| Market cap | US$62.98m |
| Earnings (TTM) | -US$4.91m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-12.8x
P/E RatioIs IRME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IRME income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$4.91m |
| Earnings | -US$4.91m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.07 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 44.1% |
How did IRME perform over the long term?
See historical performance and comparison